동물용 의약품 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 동물 유형별, 투여 경로별, 최종사용자별, 판매 채널별, 지역별 - 업계 예측(2026-2033년)

Global Veterinary Pharmaceuticals Market size was valued at USD 53.25 Billion in 2024 and is poised to grow from USD 57.24 Billion in 2025 to USD 102.09 Billion by 2033, growing at a CAGR of 7.5% during the forecast period (2026-2033).

The global veterinary pharmaceuticals market is driven by the critical role these products play in ensuring animal health, directly impacting food security and public health. Growing global demand for protein and rising pet ownership are primary factors fueling market expansion. There has been a notable transition from broad-spectrum antibiotics and antiparasitics to targeted vaccines, biologics, and diagnostic innovations in response to tightening regulations and increased awareness of antimicrobial resistance. This shift highlights the need for preventive and diagnostic solutions. Furthermore, trends like the surge in poultry production in emerging markets and enhanced pet adoption rates underscore the market's dynamics. As a result, manufacturers are increasingly allocating resources towards research and development, focusing on innovative, targeted veterinary products to meet evolving demands.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Pharmaceuticals market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Veterinary Pharmaceuticals Market Segments Analysis

Global veterinary pharmaceuticals market is segmented into product type, animal type, route of administration, end-user, sales channel and region. Based on product type, the market is segmented into vaccines, antibiotics, parasiticides, anti-inflammatory drugs and others. Based on animal type, the market is segmented into livestock, companion animals and others. Based on route of administration, the market is segmented into oral, parenteral, topical and others. Based on end-user, the market is segmented into veterinary hospitals, pharmacies, livestock farms and others. Based on sales channel, the market is segmented into veterinary distributors, direct sales, online veterinary pharmacies and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Veterinary Pharmaceuticals Market

One of the key market drivers for the global veterinary pharmaceuticals market is the increasing pet ownership and the rising awareness of animal health and welfare. As more individuals and families adopt pets, there is a growing demand for advanced veterinary care and effective pharmaceuticals to ensure the health and longevity of these animals. Additionally, the rising trend of pet humanization has led to owners willing to invest in high-quality veterinary products, driving innovation and development in pharmaceutical solutions. Furthermore, the need to prevent and treat diseases in livestock for food safety and production efficiency significantly contributes to the market's expansion.

Restraints in the Global Veterinary Pharmaceuticals Market

One significant market restraint for the global veterinary pharmaceuticals market is the increasing regulatory scrutiny and stringent approval processes imposed by government agencies. These regulations are often aimed at ensuring the safety and efficacy of veterinary medications but can result in lengthy and costly approval timelines for new products. This can deter pharmaceutical companies from investing in research and development, particularly for niche veterinary products, ultimately limiting innovation and slowing down the introduction of new therapies into the market. Such barriers may impede the overall growth potential of the veterinary pharmaceuticals sector, affecting availability and access for veterinarians and pet owners.

Market Trends of the Global Veterinary Pharmaceuticals Market

The Global Veterinary Pharmaceuticals market is witnessing a significant trend driven by the rising One Health collaboration, which encourages synergetic partnerships among animal and human health stakeholders. This integrated approach facilitates comprehensive disease surveillance and bolsters antimicrobial stewardship initiatives, thereby enhancing overall public health. As these collaborations expand, they pave the way for coordinated research and development efforts in zoonotic vaccines, diagnostics, and therapeutics, while simultaneously promoting animal welfare. Enhanced data-sharing practices and policy harmonization, along with public-private initiatives, are fostering innovation, enabling pharmaceutical companies to deliver multispecies solutions and scalable prevention programs, thus enriching the market landscape.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Veterinary Pharmaceuticals Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Vaccines
• Antibiotics
• Parasiticides
• Anti-inflammatory Drugs
• Others

Global Veterinary Pharmaceuticals Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Livestock
  • Poultry
  • Cattle
• Companion Animals
  • Dogs and Cats
  • Horses
• Others

Global Veterinary Pharmaceuticals Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Parenteral
• Topical
• Others

Global Veterinary Pharmaceuticals Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Veterinary Hospitals
• Pharmacies
• Livestock Farms
• Others

Global Veterinary Pharmaceuticals Market Size by Sales Channel & CAGR (2026-2033)

• Market Overview
• Veterinary Distributors
• Direct Sales
• Online Veterinary Pharmacies
• Others

Global Veterinary Pharmaceuticals Market Size & CAGR (2026-2033)

• North America (Product Type, Animal Type, Route of Administration, End-User, Sales Channel)
  • US
  • Canada
• Europe (Product Type, Animal Type, Route of Administration, End-User, Sales Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Animal Type, Route of Administration, End-User, Sales Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Animal Type, Route of Administration, End-User, Sales Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Animal Type, Route of Administration, End-User, Sales Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health (MSD)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Huvepharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyoritsu Seiyaku
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bimeda
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aratana Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heska Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parnell Living Science
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norbrook
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kela
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ourofino Saude Animal
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indovax
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations